Böcker av Rishabha Malviya

Discusses use of nanoparticles as nanofertifilizers and their applications in agricultural science. Summarizes research and importance of nanotechnology in abiotic stress tolerance in crop plants, its various applications in crop growth enhancement under different stress conditions, and the uses of various nanoparticles.

Studies the latest methods of gene therapy for treatment of both inherited and sporadic neurodegenerative diseases. Presents important advances in gene transfer methods and the understandings of the mechanisms behind specific neurodegenerative illnesses, placing these into the context of gene therapy approaches.

This book explores the complex world of brain tumors and the ground-breaking role that nanotechnology plays in both detection and treatment.

As digital technology advances, healthcare systems are presented with opportunities to enhance the delivery of services in a sustainable manner. This book stresses the importance of sustainable healthcare, focusing on design, waste management, supply chain efficacy, and emerging technologies like AI, robotics, and telemedicine. It highlights the need for environmentally friendly, economically viable, and socially responsible healthcare services.

The text addresses the limitations of existing therapeutic approaches using nanoparticles. It will further provide information for the development of successful cancer nanomedicine therapies. Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment. Covers the characteristics of various nanotechnology-based drug delivery systems in detail. Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction. Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research. Highlights smart strategies for improving the clinical impact of cancer nanomedicine. The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.

This book provides a deep insight into key technologies that will modernize pharmaceutical manufacturing and facilitate digital transformation.

This book provides a multidisciplinary overview of the design and implementation of systems for remote patient monitoring and healthcare.

MULTI-DRUG RESISTANCE IN CANCERThe book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents.Cancer is a major killer all over the world. Even with all the progress made, chemotherapy is still the mainstay of modern cancer treatment. The progression of the cellular defeat of numerous independent anticancer drugs in terms of their chemical structure is a major barrier to successful chemotherapy. Multi-drug resistance (MDR) is a term for the fact that most cancer patients exhibit this phenomenon. According to the numbers, drug resistance carries the blame for 90% of cancer patient deaths. Refractory cancer and tumor recurrence are common outcomes of prolonged chemotherapy. Because of the prevalence of drug-resistance mutations, the difficulty of treating tumors increases and the therapeutic efficacy of drugs decreases.Multi-Drug Resistance in Cancer: Mechanism and Treatment Strategies contains nine chapters that cover topics such as: studying the mechanics of resistance to drugs by autophagy; studies to delineate the role of efflux transporters; expression of drug transporters; resistance to targeted therapies in breast cancer; advances in metallodrug driven combination treatment for cancer; and use of natural agents for the overcoming of cancer drug resistance.The book aims to provide the latest data on the mechanisms of cellular resistance to anticancer agents currently used in clinical treatment. It provides a better understanding of the mechanisms of MDR and targets of novel chemotherapy agents which should guide future research concerning new effective strategies in cancer treatment.AudienceThis book is written for pharmaceutical and biomedical scientists and researchers at both the bench and in the clinic who are interested in the mechanisms and strategies for overcoming cancer's multi-drug resistance.